chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8/26/2012: bedtime noticed flat rash to chest area. 08/27/2012: AM awaoke, raised rash to upper back. Continued flat rash to chest area. Afebrile, no cold symptoms, no sore throat, or other cold symptoms. Usint anti-itch cream. Offered for client to use Benadryl pen. Denies new foods, meds, bathing hygiene products. Call or be seen if worsens or does not improve.
No fever. Vaccines given 2-3-11 at 4:30pm. Mom states she noticed the rash the next morning. Started on her chest as a red, macular blotchy rash, moved to back then down trunk and to her legs. None on hands, feet or face. I examined her 2/12/11 and rash persisted, petechiae noted along panty line over mons pubis and along bra line. Child is obese. BMI 99% (34).
Approx 10 minutes after vaccine given.  Started coughing uncontrollably, I would describe it as a spasming in my throat.  Profuse watering of eyes and nose.  Profuse Sweating.  I was completely fine before the vaccine, was not sick.  The acute event lasted approx 5 minutes. And constitutes to cough for several hours. Lethargic and overall didn?t feel well.  Took Benadryl and Pepcid PO.   Received  Moderna Covid vaccine 1st dose 12/30/20 and second dose  Moderna 1/27/21
OBSTRUCTIVE SLEEP APNEA ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY HYPOXIA
Left arm swelled up tight and injection site hot.  Arm swelling reduced but injection site still hot.
Patient received flu and covid vaccines, while patient was checking out it appears that she passed out. Patient was responding by the time the nurse got to the other side of the check out desk.
Short of breath/fever/muscle aches. No Rx-ASA. No contact with Dr.
I received a Tetanus/Diptheria vaccination on Sept. 25, 2008 and since then I have experienced memory difficulties; e.g., not remembering my work schedule or the name of the company I worked for 4 years ago), an inability to meditate (I have meditated for almost 40 years) and a kind of dullness or thick feeling in my brain similar to the sensation ones gets with an alcohol hangover. The adverse effects began soon afterward but I am not sure of the exact date and time.
Noticed 2 days after vaccine her (R) arm was red swollen and warm, approximately 4" circle of redness. No fever - no other symptoms. Felt like swelling was beyond the 4" circle of redness. A bruise appeared.
high fever, vomiting, severe abd pain, severe h/a, weight loss, purpuric rash, fluid in the lungs, blood in the urine, back pain, vision disturbances, fatigue, muscle aches, high BP;
Flu vaccine was administered to patient along with covid 19 vaccine (pfizer updated booster 5-11). Was not aware at time of administration that patient previously received the flu shot already in early october. Father reports no adverse events so far when call was made 2 hours after administration but will monitor patient over next couple of days. Call was made by parent to doctor for follow-up just in case.
cold symptoms; Stuffy nose; Achy body; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Stuffy nose) and PAIN (Achy body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Stuffy nose) and PAIN (Achy body). At the time of the report, NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Stuffy nose) and PAIN (Achy body) outcome was unknown.            No Concomitant and Treatment medication were reported.
7 days after vaccine- nausea, diarrhea, body aches, sore throat, fever. Could be unrelated but Urgent Care asked me to report it.
Blurry vision; Regurgitation; Loose bowel movements; Nausea; Headache; Felt fatigued; This spontaneous case was received on 05-Oct-2022 from other non-health care professional (consumer) with additional information received on the same day (reference number: SEQW22-04094) and on 18-Oct-2022 (reference number: SEQW22-04661) (being processed together) via Communications, and concerned a 32-year-old, female patient.  The patient's medical history was not reported. The patient's concomitant medications were not reported.  On 04-Oct-2022, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5 ml; route of administration, anatomical location: not reported) for prevention of influenza disease. The batch number reported was 348368 and the expiry date was 30-Jun-2023.  On 05-Oct-2022, in the morning, one day after receiving Flucelvax Quadrivalent, the patient experienced blurry vision coupled with nausea. Later in the morning, the patient experienced regurgitation and loose bowel movements. The patient also experienced headache and felt fatigued. Reset and increased fluids eased symptoms.  On the same date, the patient recovered from the events.  The case was assessed as non-serious.  Company comment: A 32-year-old patient was vaccinated with Flucelvax Quadrivalent. One day after receiving Flucelvax Quadrivalent, the patient experienced blurry vision, nausea, regurgitation and loose bowel movements. The patient also experienced headache and felt fatigued. Causal role of the suspect vaccine is assessed as possibly related, due to plausible chronology and no alternative aetiology provided.; Sender's Comments: A 32-year-old patient was vaccinated with Flucelvax Quadrivalent. One day after receiving Flucelvax Quadrivalent, the patient experienced blurry vision, nausea, regurgitation and loose bowel movements. The patient also experienced headache and felt fatigued. Causal role of the suspect vaccine is assessed as possibly related, due to plausible chronology and no alternative aetiology provided.
This spontaneous report was received from a nurse, referring to a nurse of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 27-NOV-2017, a droplet of PROQUAD lot # N020010, expiration date 13-JAN-2019 (strength, dose, route, frequency and indication were not reported) flew out and landed in the right eye after flicking syringe to get air bubble out (occupational exposure to product and exposure via eye contact). The patient experienced a slight burning sensation (eye irritation). The patient sought medical attention and was advised that the eye be flushed with water for 15 minutes and upon flushed the eye, the nurse no longer experienced the burning sensation. It was unknown if diagnostic laboratories were performed. The action taken with PROQUAD was not applicable. At the time of reporting, the outcome of eye irritation was reported as recovered on 27-NOV-2017. Additionally, the causality assessment between eye irritation and PROQUAD was not provided.
Patient had a rash develop over vaccination site 9 days after vaccination, which her MD diagnosed as COVID arm, which occurs 9-11 days after vaccine. She described a 3 inch, egg shaped rash over vaccination site. Patient's MD prescribed hydroxyzine to help with swelling and itching.
Pt reports some numbness in arm that started 2 days after getting the injection and reports it has not resolved.
he broke out in a rash all over his body; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on May2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. In May2021, the patient experienced he broke out in a rash all over his body. The patient reported that he just had his first dose 6 days ago and 2 days ago, he broke out in a rash all over his body. He took some antihistamine and was advised by his doctor to address his concerns. The patient stated he doesn't know if he should get the second dose of the vaccine and asked if he should get the second dose of the Pfizer vaccine or perhaps should he get another vaccine like the Moderna. Outcome of event was unknown.  Follow-up attempts are needed; information about lot/batch number can be obtained.
This spontaneous report was received from a registered nurse, concerning a 22 years old patient of an unknown gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On an unspecified date in February 2016, the patient was vaccinated with the first dose of GARDASIL (dose, frequency, route, lot # and expiration date were not reported) for prophylaxis, and on 16-FEB-2017, the patient received the second dose of the mentioned vaccine, that was longer than the recommend interval between doses. No adverse effects were reported. No product quality complaint (PQC) was involved.  Additional information has been requested.
Janssen vaccine given on 3/9/2021;  Admitted to the hospital on 3/16/2021 for COVID-19 infection, pneumonia, new onset a-fib, and COPD exacerbation.
Flu-like symptoms; Unexpected benefits (extreme sinus swelling and fatigue suddenly gone); sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Medical history was not provided.  The patient's past medical history included COVID-19 (Tested negative) on 28-Feb-2020, COVID-19 (Tested negative) on 05-Nov-2020, Sinus disorder NOS (Very swollen sinuses after 1st Covid infection.) on 28-Feb-2020 and Fatigue on 28-Feb-2020. Concurrent medical conditions included Gluten intolerance and Food allergy (Beef, Pork, Oranges, Green beans). Concomitant products included MULTIVITAMIN [VITAMINS NOS], VITAMIN D3, GLUCOSAMINE, LYSINE and PROBIOTICS NOS for an unknown indication.    On 11-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated 72 hours after the vaccine, the patient woke up and noticed her extreme sinus swelling (requiring chronic use of antibiotics 3 times since first COVID-19 infection in Feb/2020) was suddenly gone. The patient also noted that she had no more fatigue spells and still no sinus problems.   Most recent FOLLOW-UP information incorporated above includes: On 14-Feb-2021: No specific follow-up information recorded. On 24-Apr-2021: No specific follow-up information recorded.
arm started itching; bunch of itchy bumps on my shoulder and spread a bit to my chest; small raw patch of skin; burning sensation in left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (burning sensation in left arm), PRURITUS (arm started itching), VACCINATION SITE MASS (bunch of itchy bumps on my shoulder and spread a bit to my chest) and RASH (small raw patch of skin) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced BURNING SENSATION (burning sensation in left arm) and RASH (small raw patch of skin). On 12-Apr-2021, the patient experienced PRURITUS (arm started itching) and VACCINATION SITE MASS (bunch of itchy bumps on my shoulder and spread a bit to my chest). The patient was treated with TRIAMCINOLONE at a dose of 0.1%. On 10-Apr-2021, BURNING SENSATION (burning sensation in left arm) had resolved. At the time of the report, PRURITUS (arm started itching), VACCINATION SITE MASS (bunch of itchy bumps on my shoulder and spread a bit to my chest) and RASH (small raw patch of skin) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   List of concomitant medication were not given.
Upper arm turned black/blue first night - pain woke me up all night worse second day - third day 7/30 upper arm covered w/ hives - large and in a circle - pain worse - went to facility after calling nurse and advised to go to emergency. The doctor at facility thought I was having a heart attack - elevated blood pressure - hive turned black, then brown and lasted thru 8/19 along with upper chest pain.
Suspected COVID-19 virus infection Clinical Support 3/19/2021 Medical center RN COVID-19 virus infection Dx Medication Infusion Reason for Visit Encounter Notes All notes  Progress Notes from RN (Internal Medicine) Instructions  COVID 19 Monoclonal Antibody (MAB) Infusion Patient Reference Guide
After 2 injection pt. stated she felt like she was going to pass out. St. her vision was going dark. Face pale, assisted to clinic room to lay down - given water & cold compresses to back of neck. Pt was able to ambulate with assistance. No loss of consciousness of pt. Pt rested with nurse present for 30 mins the sat in lobby for 15-20 mins. (Approx 10AM - 10:50AM). Had pt. call us when she arrived home.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 20Apr2021 (Lot number: EW0169) at the age of 46 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "Bell's palsy" (unspecified if ongoing); "Trigeminal neuralgia" (unspecified if ongoing). Concomitant medication(s) included: LYRICA. Vaccination history included: Bnt162b2 (Dose: 01, Lot: ER8733), administration date: 30Jan2021, when the patient was 46 years old, for Covid-19 immunization. The following information was reported: DIABETES MELLITUS (hospitalization, medically significant) with onset Jan2022, outcome "unknown", described as "Diagnosed with diabetes"; BELL'S PALSY (hospitalization, medically significant), outcome "not recovered", described as "She also has bell's palsy"; HEADACHE (hospitalization) with onset Apr2021, outcome "unknown", described as "Head was pounding"; PYREXIA (hospitalization) with onset Apr2021, outcome "unknown", described as "High fever"; ASTHENIA (hospitalization) with onset Apr2021, outcome "unknown", described as "No energy at all"; BALANCE DISORDER (hospitalization) with onset Apr2021, outcome "unknown", described as "Felt off balance, kind of like her equilibrium was off"; BLOOD LACTIC ACID INCREASED (hospitalization), outcome "unknown", described as "Lactic acid was elevated"; SWELLING FACE (hospitalization), outcome "unknown", described as "Facial swelling"; TRIGEMINAL NEURALGIA (hospitalization), outcome "recovered", described as "She has trigeminal neuralgia behind her left eye"; CONDITION AGGRAVATED (hospitalization), outcome "unknown", described as "Clarifies that the flare up started before she received the vaccine but got worse after the second dose and she could not bear the pain anymore."; FEELING ABNORMAL (non-serious), outcome "unknown", described as "head was real foggy". The patient was hospitalized for headache, pyrexia (start date: 21Apr2021, discharge date: 24Apr2021, hospitalization duration: 3 day(s)). The patient underwent the following laboratory tests and procedures: blood culture: (unspecified date) negative, notes: Her doctor thought she was severely sepsis, but her results were negative; blood glucose abnormal: (unspecified date) high; blood lactic acid: (unspecified date) elevated; body temperature: (Apr2021) high, notes: High fever; glycosylated haemoglobin: (unspecified date) diabetes, notes: She asked to check her A1C and she was then diagnosed with diabetes. Therapeutic measures were taken as a result of trigeminal neuralgia. Clinical course: Symptoms after 2nd dose of Pfizer Vaccine: Head was pounding, high fever, no energy at all, felt off balance and what she means by that is her head was real foggy, kind of like her equilibrium was off. All started 6-8 hours after the 2nd dose was given. Symptoms after 3rd dose: 104.3 Fever, headache, loss of appetite, aches. only lasted 24 hours and then she bounced right back.
Pt given HPV, Tdap, and MENVEO vaccines around 9:10 AM. Verified with mom prior to injections pt has NKA, never had any adverse reactions with previous vaccines, orange juice was given prior to injections, side effects discussed. Pt tolerated injections well. Then about 5-10 min after pt appeared pale and diaphoretic. Pt assessed, BP at 9:20 AM was 71/40, pulse 57, pt put head of exam chair lowered, cool compress applied, pt given water and tolerated well. Pt continued to be monitored. BP and pulse rechecked at 9:27 AM, BP 89/57, pulse 78. Continued to monitor patient. Then a few minutes later pt vomited x1. MTH was made aware of patient status and had checked on pt when he first became diaphoretic. Rechecked pt BP and pulse at 9:40 AM, BP 90/60, pulse 83. MTH rechecked pt prior to discharge and ok to be discharged. Will follow up with patient later to see how pt is doing.
FLU LIKE SYMPTOMS STARTED ON FRIDAY  DEC THE 3RD CALLED ON SUNDAY 12/5/21. STILL FLU LIKE SYMPTOMS, WILL TRY AND SEE MD ON MONDAY 12/6/21. PATIENT REQUEST THAT THIS SHOULD BE NOTED AND SENT TO VARS
Person called the Med Det on 8/8/2012 at 7:48a.m., stating that the patient had swelling on his left shoulder and it was swelling up more, also that Pt's shoulder felt hot to touch.  He stated patient had not seeked medical care.  Person asked if we would like to see him. I advised him to start an LOD packet and take the patient to urgent care.
pt recvd Rubella vax on 6FEB92 & on 22FEB92 awoke w/pain & swelling in rt knee; lt knee swelling, swollen & painful wrists, pain awoke from sleep, numbness, paresthesias, sharp pain in hands;
Left vastus lateralis red and warm to the touch at site of administration. Advised by Dr to put cool compress and Ibuprofen if fever presents. Mom advsied to call clinic if symptoms worsen or do not imiprove.
HYPERMOBILE TYPE EHLERS-DANLOS SYNDROME (HEDS); WORSE CRAMPS; VERY DIZZY; SORE; INJECTION SITE SWELLING; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. No concomitant medications were reported.  On APR-2021, the subject experienced hypermobile type ehlers-danlos syndrome (heds). On APR-2021, the subject experienced worse cramps. On APR-2021, the subject experienced very dizzy. On APR-2021, the subject experienced sore. On APR-2021, the subject experienced injection site swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from very dizzy, and sore, had not recovered from injection site swelling, and the outcome of worse cramps and hypermobile type ehlers-danlos syndrome (heds) was not reported. This report was non-serious.; Sender's Comments: V0 20210449461, covid-19 vaccine ad26.cov2.s -Medical assessment comment not required as per standard procedure since case was assessed as Non serious.
Left arm/starting at shoulder/pain on use/raising arm or picking up/low heavy materials.
experienced a blood clot behind my left eye; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (experienced a blood clot behind my left eye) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OCULAR HYPERAEMIA (experienced a blood clot behind my left eye). At the time of the report, OCULAR HYPERAEMIA (experienced a blood clot behind my left eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Crosslinked with case MOD21-116551. AE submitted via social media. Consent for follow up declined. I experienced a blood clot behind my left eye after my first shot in February...since then I have found 4 more people with same thing....any correlation?   Reporter did not allow further contact
C/O Chest pain, fatigue, fever >100.0, the next day, post vaccination.  No medical evaluation.  Sx's resolved on their own.  CG has no ongoing complaints and is currently working
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 16-OCT-2014 the patient was vaccinated with an improperly stored ZOSTAVAX (dose, units, route of administration, anatomical location, lot number were not reported). No adverse effect were reported. Additional information is not expected because the reporter refused to be contacted for follow-up.
Feeling like having Flu; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program.  A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EW0178 and expiration date: not reported), via an unspecified route of administration, on 18Jun2021 (at the age of 50-year-old), as DOSE 2, SINGLE for covid-19 immunization. Medical history included ongoing Psychiatric issue but nothing physical. The patient's concomitant medications included some psychiatric medication. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EW0177and expiration date: not reported), via an unspecified route of administration, on 28May2021 (at the age of 50-year-old), as DOSE 1, SINGLE for covid-19 immunization and had no reaction. The patient was feeling like having a flu on 19Jun2021.  Patient don't want to report anything or sign up for anything just want to know if it's okay to take Tylenol. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
p/vax pt coughing;pt c/o chest pain, wheezing, pulse was 120, resp 28;pt was limp but responsive;taken to MD;tx w/ adrenaline & hosp overnoc for observation
BP dropped to 81/57 Pulse 65 Limbs completely limp Unable to arouse Lasted for about 5-6 hours